SSGJ-608

• Description:

  SSGJ-608 is a humanized monoclonal antibody targeting IL-17A. SSGJ-608 can be used in the research of autoimmune and inflammatory diseases, such as moderate-to-severe plaque psoriasis[1].

• UNSPSC:

  12352203

• Target:

  Interleukin Related

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• References & Citations:

  [1]Crescioli S, et al. Antibodies to watch in 2025. MAbs. 2025 Dec;17 (1) :2443538.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  Phase 3

• Isoform:

  IL-17